 Failure trimethoprim-sulfamethoxazole therapy experimental enterococcal endocarditis potential efficacy trimethoprim-sulfamethoxazole TMP-SMX serious enterococcal infections rat enterococcal endocarditis model TMP-SMX therapy mg TMP mg SMX kg body weight day intragastric gavage intravenous ampicillin therapy mg/kg day concentrations active drug serum excess MIC MBC mean residual vegetation bacterial titer TMP-SMX-treated rats similar untreated controls versus CFU/g ampicillin-treated group CFU/g equal discordance vitro activity vivo efficacy TMP-SMX serious enterococcal infection